Study of drug utilization pattern in gynecology department of tertiary care hospital of Rajasthan, India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20182466Keywords:
Drug utilization, Gynecology, Outpatient departmentAbstract
Background: With increasing awareness the flow of patients visiting gynecology outpatient department has increased. Drugs used in gynecology are one of the most selling drugs in India, however they are least studied with respect to drug utilization. Thus, present study was undertaken to analyse drug utilization pattern of Gynecology OPD in a tertiary care hospital.
Methods: A retrospective, cross sectional, observational study of prescriptions in Gynecology OPD of Jhalawar medical college, Jhalawar. Data was obtained from medical record database of patients that attended Gynecology OPD from October 2017 to March 2018 over period of six months. Prescription records of patients were screened as per inclusion and exclusion criteria and 300 prescriptions were randomly selected. Patient related, and drug related information was collected on a customized data collection sheet.
Results: The mean age of patients was 20.5±8.65 years and common age of presentation was >18-30 years. In infective cases, PID (40.6%) was common, and in non-infective cases, menorrhagia (23.8%) was common. The average number of drugs per prescription was 5.2. In drug category, minerals (46.4%) were most commonly prescribed, followed by antimicrobials (27.6%), and NSAIDs (20.1%). Polypharmacy was observed in 100% of the prescriptions.
Conclusions: In the present study all of the drugs prescribed were generic which were from the essential medical list of NLEM and WHO. This study revealed deviation from rational prescribing by the prescribers because average number of drugs per prescription was significantly higher than that recommended by WHO.
References
Truter I. A review of drug utilization studies and methodologies. Jordan J Pharmaceut Sci. 2008;1(2):91-103.
Uppal R, Nayak P, Sharma PL. Prescribing trends in internal medicine. Int J Clin Pharm Ther Toxicol. 1984;22(7):373-6.
Krishnaswamy K, Kumar BD, Radhaiah G. A drug survey- precepts and practices. Eur J Clin Pharmacol. 1985;29(3):363-70.
Pradhan SC, Shewade DG, Shashindran CH, Bapna JS. Drug utilization studies. National Med J India 1988;1:185-9.
Enwere OO, Falade CO. Drug prescribing pattern at the medical outpatient clinic of a tertiary hospital in southwestern Nigeria. Pharmacoepidemiol Drug Saf 2007;16(11):1244-9.
Supriya S, Deshmukh Yeshwant A, Mandavi R, Urmila S. Study of drug utilization pattern in the gynecology opd of a tertiary care centre. World J Pharmacy Pharmaceut Sci. 2014;3(12):916-23.
Kaur S, Talwar R, Sabharwal D, Raut DK. Knowledge about transmission dynamics of Sexually transmitted infections. Indian Med Gazette. 2011: 470-5.
Shalini S, Murthy NS, Shalini CN, Rajanna MS, Geethamani V. Study of Reproductive tract infections among women attending Urban Health Centres in Banglore City. Indian J Prev Soc Med. 2011;42(3):267-72.
Ravi R, Nair SB. Correlates of Sexually Transmitted Infections among Women in Southern India. J Fam Welfare. 2011; 57(1): 45-54.
Thappa DM, Kaimal S. Sexually Transmitted Infections in India: Current Status (Except human Immunodeficiency Virus/Aquired Immunodeficiency Syndrome). Indian J Dermatol. 2007;52(2):78-82.
Patel SV, Baxi RK, Kotecha PV. A case control study of pelvic inflammatory disease (PID) and its association with IUD (Intrauterine device). J Obstet Gynecol India. 2008; 8(4):333-7.
Gupta S, Singh O, Shukla S, Mathur RK. Epidemiology, perception and treatment of females presenting with lower urinary tract symptoms at a government hospital in central India. Internet J Surg. 2009;21(1).
Harlow SD, Campbell OM. Epidemiology of menstrual disorders in developing countries: a systematic review. Int J Obstet Gynaecol. 2004;111(1):6-16.
Adamson PC, Krupp K, Freeman AH, Klausner JD, Reingold AL, Madhivanan P. Prevalence and correlates of Primary Infertility among young Women in Mysore, India. Indian J Med Res. 2011:134(4):440-6.
NFHS key findings 2005-06. Accessed from http://www.measuredhs.com/pubs/pdf/SR128/ SR128. pdf_ on 26 April, 2016.
Bhatia JC, Cleland J. Self-reported symptoms of gynecological morbidity and their treatment in south India. Studies Fam Plann. 1995:203-16.
Sharif SI, Al-Shaqra M, Hajjar H, Shamout A, Wess L. Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J Med. 2008;3(1):10-2.
Moghadamnia AA, Mirbolooki MR, Aghili MB. General practitioner prescribing patterns in Babol city, Islamic Republic of Iran. East Mediterr Health J. 2002;8:550-5.
Shah BK, Shah VN. Antimicrobial use by the department of obstetrics and gynecology of a tertiary care hospital: Analysis for rationality and other aspects. J Obstet Gynecol Ind. 2004;54(4):387-92.
Sihavong A, Phouthavane T, Lundborg CS, Sayabounthavong K, Syhakhang L, WahlstrÖm R. Reproductive tract infections among women attending a gynecology outpatient department in Vientiane, Lao PDR. Sexually Transmitted Dis. 2007;34(10):791-5.
World Health Organization (WHO). International Network for Rational Use of Drugs and World Health Organization. How to investigate drug use in health facilities: Selected drug use indicators 1993. EDM Research Series No. 7 (WHO/DAP/93.1).
Dhaubhadel P, Vaidya A, Chaudhary P. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic acid. J Nepal Med Assoc. 2008; 47(170):71-76.
National List of Essential Medicines 2015. Accessed from http://cdsco.nic.in /WriteReadData /NLEM-2015/NLEM,%202015.pdf on 27 April, 2016
WHO List of Essential Medicines 2015. Available at http://www.who.int/medicines/ publications/essentialmedicines/EML2015_8-May-15.pdf on 27 April, 2016.
